A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Thomas Jefferson University
Thomas Jefferson University
CytomX Therapeutics
City of Hope Medical Center
Stanford University
BeiGene
National Cancer Institute (NCI)
Bristol-Myers Squibb
Nektar Therapeutics
Atara Biotherapeutics
Provectus Pharmaceuticals
Roswell Park Cancer Institute
Roswell Park Cancer Institute
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Roswell Park Cancer Institute
Roswell Park Cancer Institute
University of Chicago
OHSU Knight Cancer Institute
Fred Hutchinson Cancer Center
UNC Lineberger Comprehensive Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Alliance for Clinical Trials in Oncology
Fred Hutchinson Cancer Center
University of Rochester
Bristol-Myers Squibb
City of Hope Medical Center